Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be Webcast

  Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be
                                   Webcast

PR Newswire

PLEASANTON, Calif., Aug. 22, 2013

PLEASANTON, Calif., Aug. 22, 2013 /PRNewswire/ --Thoratec Corporation
(NASDAQ: THOR), a world leader in device-based mechanical circulatory support
therapies to save, support and restore failing hearts, said today it will be
participating in the Morgan Stanley 2013 Health Care Conference on Monday,
September 9.

Taylor C. Harris, Vice President and Chief Financial Officer, will provide an
update on the company, beginning at 10:50 a.m., Pacific Daylight Time (1:50
p.m., Eastern Daylight Time).

The presentation will be available through the conference web site at
http://cc.talkpoint.com/morg007/090913a_mc/?entity=104_CVDC2KU, or on the
company's web site at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's web site at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered
trademarks of Thoratec Corporation. CentriMag and PediMag are registered
trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec
Switzerland GmbH.

SOURCE Thoratec Corporation

Website: http://www.thoratec.com
Contact: Neil Meyer, Director of Investor Relations, Thoratec Corporation,
(925) 738-0029